In this issue:
Macitentan for PAH
Riociguat for PAH
Riociguat for CTEPH
Death in PAH
Pulmonary hypertension referrals to tertiary centres
Sildenafil for respiratory outcomes in COPD
Edoxaban vs. warfarin for symptomatic VTE
Apixaban for extended VTE treatment
Dabigatran dosing and renal function/drug interactions
Out- vs. inpatient PE treatment
Delayed presentation of suspected PE
DVT/PE risk in asthma
Please login below to download this issue (PDF)